http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-202019005745-U1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_831ecb70e90f69062fc8a6a1112a4934
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9861b35d00c508fbdba6e1f56562d82e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-202019005745-U1
titleOfInvention Orodispersible tablets comprising glycopyrrolate with increased bioavailability
abstract Porous orodispersible tablet with microscopic pores, comprising a therapeutically effective amount of glycopyrrolate, the porous orodispersible tablet with microscopic pores disintegrating in the mouth in less than 60 seconds, the porous orodispersible tablet with microscopic pores by freeze-drying a liquid formulation having a pH in the range of 4.0 to 6.5, preferably in the range from 4.0 to 5.0, is produced, the liquid formulation comprising at least one filler, at least one binder, at least one emulsifier, at least one disintegrant and water; andwherein the porous orodispersible tablet with microscopic pores preferably has an increased bioavailability compared to a reference tablet which comprises the same amount of glycopyrrolate.
priorityDate 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008260823-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9345771-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5298261-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7091236-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423352616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51064083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453416683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425172137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407699550

Total number of triples: 71.